Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Clinical trial NCT07360314 · RECRUITING
Trial details
- NCT number
- NCT07360314
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-13
- Primary completion
- 2028-09-20
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.